Pneumatic Medicine: A Transformative Treatment for Diabetic Peripheral Neuropathy

Inclusion Criteria: * Patient diagnosed with type 1 or type 2 diabetes * Patient diagnosed with distal symmetric polyneuropathy (DPN) attributable to diabetes * A1C ≤ 11% * Abnormal peroneal motor nerve conduction study where CMAP amplitude is less than 4 mV bilaterally. Exclusion Criteria: * Refuses consent * Unlikely to be compliant with the research protocol as judged by the clinical investigator * Neuropathy documented to be caused by something other than diabetes * Medication for neuropathic pain initiated within the previous 3 months (to avoid confounding the results of the study) * Medication for glucose control changed within the previous 3 months (to avoid confounding the results of the study) * Documented DVT within the previous 3 months (since an acute DVT is a contraindication for Pneumatic Medicine treatment) * Significant hepatic disease as judged by the clinical investigator (that might cause neuropathy unrelated to diabetes) * Documented cancer treatment within the past 5 years (that might cause neuropathy unrelated to diabetes) * History of exposure to neurotoxins or heavy metals (that might cause neuropathy unrelated to diabetes) * Documented alcohol or drug abuse (that might cause neuropathy unrelated to diabetes) * Documented major psychiatric disorder (that could contribute to non-adherence to the protocol) * Presence of a major lower extremity amputation (since unable to perform bilateral distal sensory perception testing of the feet and NCS on the peroneal motor nerve) * Significant peripheral arterial disease defined as an ankle-brachial index ("ABI") \< 0.6 (to avoid critical limb ischemia and thus the high likelihood of the patient requiring a major amputation in the near future with drop out from the study) * Severe lower extremity edema as judged by the clinical investigator (in order to not confound the results) * End stage DPN where the peroneal motor nerve conduction results of both legs show an Amplitude = 0 mV * Currently participating in another clinical trial